Health product recall

OraVerse: Six wholesalers do not hold an establishment license for sale of the product in Canada

Brand(s)
Last updated

Summary

Product
Phentolamine Mesylate
Issue
Health products - Establishment/Site licensing
What to do

Consult your health care professional if you have any health concerns.

Distribution
Alberta
Ontario
Quebec

Affected products

Brand Product Name Market Authorization Dosage Form Strength Lot
OraVerse Phentolamine mesylate DIN 2421666 Solution n/a D03743BB, D03743BD, D04182BA, D04182BD, D04182BF

Issue

Six wholesalers that received product from the regulated party do not hold an establishment license for sale of the product in Canada.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Wholesalers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Septodont (Novocol Pharmaceutical of Canada Inc.)

25 Wolseley Court, Cambridge, ON, N1R 6X3

Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
Alberta
Ontario
Quebec
Recall class
Type III
Identification number
RA-74509